latest news releases from the newsroom
FCStone Group, Inc.
FCStone Group, Inc. Announces Strong Fiscal 2007 Third Quarter Results and Three-for-Two Stock Split
WEST DES MOINES, Iowa, July 12, 2007 (PRIME NEWSWIRE) -- FCStone Group, Inc. (Nasdaq:FCSX), a commodity risk management firm, today announced higher year-over-year revenues and net income for its fiscal third quarter ending May 31, 2007, and a three-for-two stock split, which will be implemented by way of a 50% stock dividend.
Asia Properties, Inc.
Asia Properties, Inc. Reports Realized Revenues to Shareholders
BELLINGHAM, Wash., July 12, 2007 (PRIME NEWSWIRE) -- Asia Properties, Inc. (Pink Sheets:ASPZ) issued an update to shareholders today in regard to actual revenues received by Asia Properties from the sale of 5 of the 13 resort villas owned by the company in the Phase 1 subdivision of the Baan Naiyang Resort located in Phuket, Thailand.
Builders FirstSource, Inc.
Builders FirstSource to Host Second Quarter 2007 Financial Results Conference Call and Webcast
DALLAS, July 12, 2007 (PRIME NEWSWIRE) -- Builders FirstSource, Inc. (Nasdaq:BLDR), a leading supplier and manufacturer of structural and related building products for residential new construction, will hold a conference call and webcast on Friday, July 27, to discuss the company's second quarter 2007 financial results and other business matters. The teleconference will begin at 10:00 a.m. Central Time and will be hosted by Floyd Sherman, Chief Executive Officer, Kevin O'Meara, President and Chief Operating Officer, and Charles Horn, Senior Vice President and Chief Financial Officer. A copy of the company's press release announcing its financial results and other statistical information about the periods to be presented is expected to be made available after the market closes on July 26, at the Investors section of the Builders FirstSource, Inc. Web site, at www.bldr.com.
Tikvah Therapeutics, Inc.
Tikvah Therapeutics Raises $10 Million Gross Proceeds in Private Financing
ATLANTA, July 12, 2007 (PRIME NEWSWIRE) -- Tikvah Therapeutics, Inc., a biopharmaceutical company that focuses on novel therapeutic treatments for diseases of the central nervous system, including neurology and psychiatry disorders, announced today it has completed a private financing with gross proceeds of $10 million in a convertible note financing. Paramount BioCapital, Inc. served as the placement agent. Tikvah Therapeutics was founded by Paramount BioSciences, LLC.